All companies › TRDA

TRDA · Entrada Therapeutics, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells6
Research cases0
Last filing2026-08-26

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-24 — MPM BioVentures 2014, L.P. · sold 21,623 @ $7.34 2026-08-24 — MPM BIOVENTURES 2018, L.P. · sold 21,623 @ $7.34 2026-08-25 — MPM BioVentures 2014, L.P. · sold 26,522 @ $7.54 2026-08-25 — MPM BIOVENTURES 2018, L.P. · sold 26,522 @ $7.54 2026-08-26 — MPM BioVentures 2014, L.P. · sold 14,569 @ $7.06 2026-08-26 — MPM BIOVENTURES 2018, L.P. · sold 14,569 @ $7.06
2026-08-242026-08-26

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

MPM BioVentures 2014, L.P. Title not stated
MPM BIOVENTURES 2018, L.P. Title not stated
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $TRDA is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-08-26', 'insider_name': 'MPM BioVentures 2014, L.P.', 'insider_title': '', 'transaction_type': 'Open-market sell', 'shares': 14569.0, 'price': 7.06, 'value': 102857.14, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'MPM BIOVENTURES 2018, L.P.', 'insider_title': '', 'transaction_type': 'Open-market sell', 'shares': 14569.0, 'price': 7.06, 'value': 102857.14, 'is_buy': False}, {'transaction_date': '2026-08-25', 'insider_name': 'MPM BioVentures 2014, L.P.', 'insider_title': '', 'transaction_type': 'Open-market sell', 'shares': 26522.0, 'price': 7.54, 'value': 199975.88, 'is_buy': False}, {'transaction_date': '2026-08-25', 'insider_name': 'MPM BIOVENTURES 2018, L.P.', 'insider_title': '', 'transaction_type': 'Open-market sell', 'shares': 26522.0, 'price': 7.54, 'value': 199975.88, 'is_buy': False}, {'transaction_date': '2026-08-24', 'insider_name': 'MPM BioVentures 2014, L.P.', 'insider_title': '', 'transaction_type': 'Open-market sell', 'shares': 21623.0, 'price': 7.34, 'value': 158712.82, 'is_buy': False}, {'transaction_date': '2026-08-24', 'insider_name': 'MPM BIOVENTURES 2018, L.P.', 'insider_title': '', 'transaction_type': 'Open-market sell', 'shares': 21623.0, 'price': 7.34, 'value': 158712.82, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for TRDA today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.